exsure.in

WE ARE

Developing Next generation Nano Drug delivery Platform

MISSION

Our mission is to revolutionize and democratize cancer therapy by making quality & affordable cancer treatment available for all

EXSURE

ABOUT US

About Exsure

India’s First Patented Exosome-based Targeted Anti-Cancer Drug Delivery Platform which can target both cancer and cancer-stem cells.
EXSURE is an R&D focussed biotech startup aims at reducing the toxic effects of chemotherapy and chances of cancer relapse improving the quality of lives of patients suffering from cancer.
EXSURE has launched India’s 1st 2-in-1 Exosome Isolation Reagent EXOSURE, which can isolate exosomes from cell-culture conditioned medium and human serum.
EXSURE is about to launch LEUCOSURE (Lymphocyte Isoltion Reagent which is stable at Room Temperature) and DENDROSURE (India’s first mature dendritic cell culture medium which can convert monocytes into mature dendritic cells within 48 hours)
ExSURE PVT. LTD. has became a member of The Indian Extracellular Vesicles Society (IEVS).

BOOK YOUR REAGENT

Email

swastika.paul@exsure.in / abhishek.dutta@exsure.in

Contact

7980402341 / 7980457752

Services

Cancer stem cell isolation from patient tumor and blood samples
Characterization of cancer stem cells isolated from various sources
Generation of human cancer tissue derived stem cell bank
Isolation of exosomes from various sources.
Characterization of exosomes isolated from various sources.
Generation of bioengineered targeted exosomes and drug delivery.
Grant Writing support and guidance

Contact

USP OF EXSURE

At ExSURE , we are developing India's first of its kind innovation involving exosome-based anti-cancer drug delivery platform targeting relapse-causing cancer stem cells.